Fortress Investment Group’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
Other funds holding RNAM
Fortress Investment Group's RNAM Position: Q1 2026 in Review
Fortress Investment Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 34,402 shares — an estimated $2.48M sold.
Fortress Investment Group first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $2.48M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Fortress Investment Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Fortress Investment Group sold 34,402 Avidity Biosciences shares in Q1 2026, an estimated $2.48M.
- Fortress Investment Group first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
- Fortress Investment Group's Avidity Biosciences position peaked at $2.48M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Fortress Investment Group's 13F filing for Q1 2026, filed 15 May 2026.